Stenger, Elizabeth O <br/><br/>
Use of Alefacept for Preconditioning in Multiply Transfused Pediatric Patients with Nonmalignant Diseases.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  Oct 2015 
 - 1845-52 p.  digital 
<br/><br/> Publication Type: Case Reports; Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1523-6536 
<br/><br/><label>Standard No.: </label>10.1016/j.bbmt.2015.06.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alefacept<br/>Anemia, Aplastic--therapy<br/>Blood Component Transfusion--statistics & numerical data<br/>Bone Marrow Transplantation<br/>CD2 Antigens--immunology<br/>Child<br/>Cord Blood Stem Cell Transplantation<br/>Dyskeratosis Congenita--therapy<br/>Fanconi Anemia--therapy<br/>Female<br/>Graft Survival<br/>Graft vs Host Disease--etiology<br/>Historically Controlled Study<br/>Humans<br/>Immunologic Memory<br/>Immunophenotyping<br/>Infant<br/>Killer Cells, Natural--drug effects<br/>Lymphocyte Depletion--methods<br/>Male<br/>Pilot Projects<br/>Recombinant Fusion Proteins--supply & distribution<br/>T-Lymphocyte Subsets--drug effects<br/>Transplantation Conditioning<br/>Unrelated Donors